Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?

BACKGROUND: Botulinum toxin type A (BTX-A) has been reported to have analgesic effects independent of its action on muscle tone, mostly by acting on neurogenic inflammatory mediators and controlling the neurotransmitter release of sensory and autonomic nerve terminals that are involved in many chron...

Descripción completa

Detalles Bibliográficos
Autores principales: Shehata, Hatem S, El-Tamawy, Mohamed S, Shalaby, Nevin M, Ramzy, Gihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177416/
https://www.ncbi.nlm.nih.gov/pubmed/24251833
http://dx.doi.org/10.1186/1129-2377-14-92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177416/
https://www.ncbi.nlm.nih.gov/pubmed/24251833
http://dx.doi.org/10.1186/1129-2377-14-92

Ejemplares similares